Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (6)
Type
(
1 selected
)
Type
Guidance (1861)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (761)
Apply filters
Showing 581 to 590 of 1861
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Epilepsies in children, young people and adults
NG217
27 April 2022
27 April 2022
Epiretinal brachytherapy for wet age-related macular degeneration
IPG415
16 December 2011
16 December 2011
Episcissors-60 for mediolateral episiotomy
MTG47
11 February 2020
11 February 2020
Epithelial radiofrequency ablation for Barrett's oesophagus
IPG344
26 May 2010
26 May 2010
Eptinezumab for preventing migraine
TA871
1 March 2023
1 March 2023
Erenumab for preventing migraine
TA682
10 March 2021
10 March 2021
Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen
TA515
28 March 2018
28 March 2018
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens
TA423
21 December 2016
21 December 2016
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy
TA374
16 December 2015
16 December 2015
Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer
TA258
27 June 2012
27 June 2012
Previous page
1
…
57
58
Current page
59
60
61
…
187
Page
59
of
187
Next page
Results per page
10
25
50
All
Back to top